The RAS/BRAF/MEK/ERK pathway, which operates downstream of various growth factor receptors, including EGFR, is often overexpressed and activated in CRC, particularly in cases with dysregulated MAPK pathway signaling (225). Here, MAP2K7 is linked to colorectal carcinoma.